rs28494155

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000651929.2(FHL1):​c.-261A>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 17919 hom., 14859 hem., cov: 15)
Exomes 𝑓: 0.69 ( 87 hom. 93 hem. )
Failed GnomAD Quality Control

Consequence

FHL1
ENST00000651929.2 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.643

Publications

2 publications found
Variant links:
Genes affected
FHL1 (HGNC:3702): (four and a half LIM domains 1) This gene encodes a member of the four-and-a-half-LIM-only protein family. Family members contain two highly conserved, tandemly arranged, zinc finger domains with four highly conserved cysteines binding a zinc atom in each zinc finger. Expression of these family members occurs in a cell- and tissue-specific mode and these proteins are involved in many cellular processes. Mutations in this gene have been found in patients with Emery-Dreifuss muscular dystrophy. Multiple alternately spliced transcript variants which encode different protein isoforms have been described.[provided by RefSeq, Nov 2009]
FHL1 Gene-Disease associations (from GenCC):
  • X-linked myopathy with postural muscle atrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P
  • myopathy, reducing body, X-linked, early-onset, severe
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • reducing body myopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked scapuloperoneal muscular dystrophy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant X-136147468-A-C is Benign according to our data. Variant chrX-136147468-A-C is described in ClinVar as Benign. ClinVar VariationId is 1248339.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.635 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000651929.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHL1
NR_027621.2
n.311+456A>C
intron
N/A
FHL1
NM_001159702.3
MANE Plus Clinical
c.-261A>C
upstream_gene
N/ANP_001153174.1Q13642-2
FHL1
NM_001369326.1
c.-511A>C
upstream_gene
N/ANP_001356255.1Q13642-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FHL1
ENST00000651929.2
c.-261A>C
5_prime_UTR
Exon 1 of 7ENSP00000499016.1Q13642-1
FHL1
ENST00000629039.2
TSL:2
c.-101+456A>C
intron
N/AENSP00000486439.1Q13642-1
FHL1
ENST00000394155.8
TSL:5 MANE Plus Clinical
c.-261A>C
upstream_gene
N/AENSP00000377710.2Q13642-2

Frequencies

GnomAD3 genomes
AF:
0.751
AC:
65343
AN:
86956
Hom.:
17917
Cov.:
15
show subpopulations
Gnomad AFR
AF:
0.617
Gnomad AMI
AF:
0.768
Gnomad AMR
AF:
0.750
Gnomad ASJ
AF:
0.731
Gnomad EAS
AF:
0.683
Gnomad SAS
AF:
0.729
Gnomad FIN
AF:
0.872
Gnomad MID
AF:
0.695
Gnomad NFE
AF:
0.817
Gnomad OTH
AF:
0.711
GnomAD4 exome
AF:
0.694
AC:
359
AN:
517
Hom.:
87
Cov.:
0
AF XY:
0.769
AC XY:
93
AN XY:
121
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AF:
0.695
AC:
348
AN:
501
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.800
AC:
8
AN:
10
Other (OTH)
AF:
0.500
AC:
3
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.751
AC:
65347
AN:
86964
Hom.:
17919
Cov.:
15
AF XY:
0.809
AC XY:
14859
AN XY:
18362
show subpopulations
African (AFR)
AF:
0.617
AC:
13741
AN:
22270
American (AMR)
AF:
0.750
AC:
6153
AN:
8203
Ashkenazi Jewish (ASJ)
AF:
0.731
AC:
1654
AN:
2262
East Asian (EAS)
AF:
0.683
AC:
1752
AN:
2567
South Asian (SAS)
AF:
0.731
AC:
1300
AN:
1778
European-Finnish (FIN)
AF:
0.872
AC:
2396
AN:
2747
Middle Eastern (MID)
AF:
0.690
AC:
120
AN:
174
European-Non Finnish (NFE)
AF:
0.817
AC:
36989
AN:
45259
Other (OTH)
AF:
0.712
AC:
841
AN:
1182
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
722
1444
2167
2889
3611
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
514
1028
1542
2056
2570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.540
Hom.:
1680

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
7.7
DANN
Benign
0.73
PhyloP100
-0.64
PromoterAI
0.017
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28494155; hg19: chrX-135229627; API